Clinical review compares whole-body MRI and CT for diagnosing and managing hematologic malignancies, indicating practical considerations for each modality.
Key Points
This review aims to evaluate the comparative effectiveness of whole-body MRI and CT in diagnosing and managing hematologic malignancies and bone marrow disorders.
Provided a scenario-based comparison of WBCT and WBMRI across various clinical applications.
Synthesize data from 3 studies involving 152 patients to assess CT-MRI concordance in multiple myeloma.
Discussed emerging CT techniques and their implications for marrow imaging.
The pooled CT-MRI concordance in multiple myeloma was 0.895 (95% CI: 0.834-0.935), indicating substantial agreement.
The broader pooled concordance across other disease categories was 0.797 (95% CI: 0.667-0.885), reflecting variability in clinical scenarios.
WBMRI is preferable for non-neoplastic marrow disorders, while FDG-PET/CT is standard for adult lymphoma.